SE7804446L - Tienamycinderivat - Google Patents

Tienamycinderivat

Info

Publication number
SE7804446L
SE7804446L SE7804446A SE7804446A SE7804446L SE 7804446 L SE7804446 L SE 7804446L SE 7804446 A SE7804446 A SE 7804446A SE 7804446 A SE7804446 A SE 7804446A SE 7804446 L SE7804446 L SE 7804446L
Authority
SE
Sweden
Prior art keywords
tienamycin
derivatives
tienamycin derivatives
Prior art date
Application number
SE7804446A
Other languages
English (en)
Swedish (sv)
Inventor
B G Christensen
W J Leanza
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Publication of SE7804446L publication Critical patent/SE7804446L/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D477/00Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring
    • C07D477/10Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • C07D477/12Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6
    • C07D477/16Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6 with hetero atoms or carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 3
    • C07D477/20Sulfur atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6561Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings
    • C07F9/65611Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings containing the ring system (X = CH2, O, S, NH) optionally with an additional double bond and/or substituents, e.g. penicillins and analogs

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
SE7804446A 1977-05-05 1978-04-19 Tienamycinderivat SE7804446L (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/793,974 US4235917A (en) 1977-05-05 1977-05-05 N-Alkyl-N-acyl derivatives of thienamycin

Publications (1)

Publication Number Publication Date
SE7804446L true SE7804446L (sv) 1978-11-06

Family

ID=25161301

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7804446A SE7804446L (sv) 1977-05-05 1978-04-19 Tienamycinderivat

Country Status (14)

Country Link
US (1) US4235917A (ru)
JP (1) JPS53137992A (ru)
BE (1) BE866660A (ru)
CH (1) CH638209A5 (ru)
DE (1) DE2819479A1 (ru)
DK (1) DK170678A (ru)
ES (1) ES469425A1 (ru)
FR (1) FR2389629B1 (ru)
GB (1) GB1604276A (ru)
IE (1) IE46877B1 (ru)
IT (1) IT1105291B (ru)
LU (1) LU79597A1 (ru)
NL (1) NL7804230A (ru)
SE (1) SE7804446L (ru)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4839352A (en) * 1975-11-21 1989-06-13 Merck & Co., Inc. N-acyl derivatives of thienamycin
US4318912A (en) * 1979-01-02 1982-03-09 Merck & Co., Inc. 6-(1-Hydroxyethyl)-3-substituted-1-azabicyclo(3.2.0)-hept-2-en-7-one-2-carboxylic acid
US4376774A (en) * 1979-05-29 1983-03-15 Merck & Co., Inc. Antibiotic N-heterocyclyl thienamycin
EP0024832B1 (en) * 1979-08-10 1985-03-13 Beecham Group Plc Beta-lactam antibiotics, their preparation, pharmaceutical compositions containing them and their preparation
US4361512A (en) * 1980-11-26 1982-11-30 Merck & Co., Inc. 2-Substituted thio-6-substituted-carbapen-2-em-3-carboxylic acids
JPS5857392A (ja) * 1981-10-02 1983-04-05 Sanraku Inc 新規な抗生物質oa−6129のリン酸エステル
US4642341A (en) * 1982-04-09 1987-02-10 Bristol-Myers Company Carbapenem antibiotics
US4710568A (en) * 1982-04-09 1987-12-01 Bristol-Myers Company Carbapenem antibiotics
US4552696A (en) * 1982-04-09 1985-11-12 Bristol-Myers Company Carbapenem antibiotics
ZA832412B (en) * 1982-04-09 1983-12-28 Bristol Myers Co Carbapenem antibiotics
US4529597A (en) * 1982-04-19 1985-07-16 Merck & Co., Inc. Substituted 1-azabicyclo(3.2.0)hept-6-en-2-one-7-carboxylic acids
US4665170A (en) * 1982-06-18 1987-05-12 Bristol-Myers Company Carbapenem antibiotics
US4536335A (en) * 1982-06-18 1985-08-20 Bristol-Myers Company Carbapenem antibiotics
ZA834472B (en) * 1982-06-18 1984-03-28 Bristol Myers Co Carbepenem antibiotics
US4640799A (en) * 1982-06-18 1987-02-03 Bristol-Myers Company Carbapenem antibiotics
US4746736A (en) * 1982-09-28 1988-05-24 Bristol-Myers Company Carbapenem antibiotics
US4732977A (en) * 1982-09-28 1988-03-22 Bristol Myers Company Carbapenem antibiotics
ZA841643B (en) * 1983-03-08 1984-10-31 Bristol Myers Co Carbapenem process
US4992542A (en) * 1984-01-24 1991-02-12 Merck & Co., Inc. 2-substituted-6-carbadethiapen-2-em-3-carboxylic acids
US5496816A (en) * 1994-03-14 1996-03-05 Merck & Co., Inc. Carbapenem antibacterial compounds, compositions containing such compounds and methods of treatment

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3950357A (en) * 1974-11-25 1976-04-13 Merck & Co., Inc. Antibiotics
CH632508A5 (de) * 1975-11-21 1982-10-15 Merck & Co Inc Verfahren zur herstellung von neuen estern des n-acylierten thienamycins.
US4150145A (en) * 1977-09-15 1979-04-17 Merck & Co., Inc. N-alkylated derivatives of thienamycin sulfoxide and sulfone

Also Published As

Publication number Publication date
GB1604276A (en) 1981-12-09
IE780899L (en) 1978-11-05
JPS53137992A (en) 1978-12-01
ES469425A1 (es) 1980-01-01
NL7804230A (nl) 1978-11-07
LU79597A1 (fr) 1979-02-02
DE2819479C2 (ru) 1992-04-30
FR2389629A1 (ru) 1978-12-01
BE866660A (fr) 1978-11-03
US4235917A (en) 1980-11-25
IT7849175A0 (it) 1978-05-03
JPH0222076B2 (ru) 1990-05-17
IE46877B1 (en) 1983-10-19
FR2389629B1 (ru) 1980-06-20
IT1105291B (it) 1985-10-28
CH638209A5 (de) 1983-09-15
DK170678A (da) 1979-01-16
DE2819479A1 (de) 1978-11-16

Similar Documents

Publication Publication Date Title
SE7805879L (sv) Mevalonolaktonderivat
PT68458A (pt) Triphenylalkene derivatives
AT376049B (de) Zielverfolger
AR221072A1 (es) Banco-escalera
SE7711581L (sv) Xantin-derivat
DK543178A (da) Thiodydantoinderivater
SE7803057L (sv) Bensimidazolderivat
SE7804446L (sv) Tienamycinderivat
AT367290B (de) Menstrualtampon
SE7805260L (sv) Alkylendiaminderivat
AT361804B (de) Haarschneidemaschine
SE7801997L (sv) Dipeptidderivat
SE7800982L (sv) Meta-sulfonamido-bensamid-derivat
SE7805140L (sv) Bensimidazolderivat
FI783393A (fi) 2-imino-imidazolidinderivat
SE7801312L (sv) Oxadiazolopyrimidin-derivat
AR215677A1 (es) Tarugo
FI780343A (fi) Oxadiazolopyrimidinderivat
SE7803418L (sv) Kinazolinderivat
BR7808456A (pt) Novos derivados de pirazina
AT359804B (de) Abwaelzfraeser
MC1195A1 (fr) Derives acyles
AT374008B (de) Kuevette
AT368870B (de) Rumpforthese
FI780915A (fi) Icke-glykocidiska teofyllin-socker-derivat